Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

(2013) Bernhard J. Steinhoff et al.   EPILEPSIA

Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register: Table 1

(2013) Udo Carl Wieshmann et al.   BMJ Open

Beneficial and Adverse Psychotropic Effects of Antiepileptic Drugs in Patients with Epilepsy

(2012) John Piedad et al.   CNS DRUGS

Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology

(2012) Marco Mula et al.   EPILEPSIA

Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

(2012) Jacqueline A. French et al.   EPILEPSIA

Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307

(2012) Gregory L. Krauss et al.   EPILEPSIA

Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

(2012) J. A. French et al.   NEUROLOGY

Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures

(2012) G. L. Krauss et al.   NEUROLOGY

Treatment-emergent psychiatric adverse events of antiepileptic drugs in epilepsy: how can we avoid them?

(2012) Marco Mula   Neuropsychiatry

Self-reported symptoms in patients on antiepileptic drugs in monotherapy

(2011) U. C. Wieshmann et al.   ACTA NEUROLOGICA SCANDINAVICA

Tolerability and safety of perampanel: two randomized dose-escalation studies

(2011) G. L. Krauss et al.   ACTA NEUROLOGICA SCANDINAVICA